secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ginkgo Bioworks Holdings, Inc. (DNA)
CIK:        0001830214
Form:       8-K
Filed at:   2021-09-20T23:59:59+00:00
Accession:  0001193125-21-277420
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 2.01, 9.01, 3.02, 4.01, 3.03, 8.01, 5.01, 5.02, 5.03, 5.06
LLM model:  deepseek-v4-flash:cloud@v2

Ginkgo Bioworks completes $15.8B SPAC merger; begins NYSE trading under DNA
---------------------------------------------------------------------------

- Transaction valued at ~$15.8B; Old Ginkgo equity holders received ~49.08 New Ginkgo shares per old share.
- PIPE investment of $760M (76M shares at $10.00) raised concurrently with closing.
- Earn-out shares up to 188.7M shares vest based on stock price targets ($12.50/$15.00/$17.50/$20.00) over 5 years.
- Post-closing shares outstanding: ~1.75B Class A and B common (excluding earn-out and warrants); total ~2.01B.
- Class A common and warrants began trading on NYSE Sept 17, 2021 under symbols DNA and DNA.WS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/0001193125-21-277420-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1830214/000119312521277420/d186750d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-277420

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer